UNSPSC 51263136: Timolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula 2C13H24N4O3S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 817W3C6175, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)-oxy)-, (+-)- but generally known as timolol, which bears US NIH Compound Identifier 5478. European Medicines Agency schedules Timolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11069MIG.

UNSPSC 51263136 Timolol, a Commodity-tier code, does not align with the recent state and local procurement activity tagged under it. The sole recent opportunity in the source—Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems—concerns emergency overdose-reversal medications and harm-reduction equipment, not timolol, which is a beta-blocker used primarily for hypertension and glaucoma. The mismatch suggests either a classification error in the source data or a misapplication of the code to the Seminole County solicitation. Timolol itself—a prescription ophthalmic and systemic pharmaceutical—would typically fall under pharmaceutical product codes rather than a naloxone-specific commodity designation.

The source provides no additional recent opportunities under UNSPSC 51263136 beyond the Seminole County record. Without a substantive body of aligned recent solicitations, geographic concentration cannot be characterized and no pattern of issuing-body repeat activity emerges. The code shows little relevant recent activity as currently tagged in the available source material.